These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15369802)

  • 1. Influence of lipophilicity on the interactions of hydroxy stilbenes with cytochrome P450 3A4.
    Regev-Shoshani G; Shoseyov O; Kerem Z
    Biochem Biophys Res Commun; 2004 Oct; 323(2):668-73. PubMed ID: 15369802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resveratrol, a red wine constituent, is a mechanism-based inactivator of cytochrome P450 3A4.
    Chan WK; Delucchi AB
    Life Sci; 2000 Nov; 67(25):3103-12. PubMed ID: 11125847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of trans-resveratrol on 7-benzyloxy-4-trifluoromethylcoumarin O-dealkylation catalyzed by human recombinant CYP3A4 and CYP3A5.
    Chang TK; Yeung RK
    Can J Physiol Pharmacol; 2001 Mar; 79(3):220-6. PubMed ID: 11294598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trans-resveratrol, but not other natural stilbenes occurring in food, carries the risk of drug-food interaction via inhibition of cytochrome P450 enzymes or interaction with xenosensor receptors.
    Hyrsova L; Vanduchova A; Dusek J; Smutny T; Carazo A; Maresova V; Trejtnar F; Barta P; Anzenbacher P; Dvorak Z; Pavek P
    Toxicol Lett; 2019 Jan; 300():81-91. PubMed ID: 30394306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liquid chromatography/tandem mass spectrometric determination of inhibition of human cytochrome P450 isozymes by resveratrol and resveratrol-3-sulfate.
    Yu C; Shin YG; Kosmeder JW; Pezzuto JM; van Breemen RB
    Rapid Commun Mass Spectrom; 2003; 17(4):307-13. PubMed ID: 12569440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biotransformation of parathion in human liver: participation of CYP3A4 and its inactivation during microsomal parathion oxidation.
    Butler AM; Murray M
    J Pharmacol Exp Ther; 1997 Feb; 280(2):966-73. PubMed ID: 9023313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of In Vitro and Predictive In Silico Models to Study the Inhibition of Cytochrome P4503A by Stilbenes.
    Basheer L; Schultz K; Fichman M; Kerem Z
    PLoS One; 2015; 10(10):e0141061. PubMed ID: 26485399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential inhibition of human cytochrome P450 enzymes by epsilon-viniferin, the dimer of resveratrol: comparison with resveratrol and polyphenols from alcoholized beverages.
    Piver B; Berthou F; Dreano Y; Lucas D
    Life Sci; 2003 Jul; 73(9):1199-213. PubMed ID: 12818727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CYP3A4 active site volume modification by mutagenesis of leucine 211.
    Fowler SM; Taylor JM; Friedberg T; Wolf CR; Riley RJ
    Drug Metab Dispos; 2002 Apr; 30(4):452-6. PubMed ID: 11901100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro oxidative metabolism of cajaninstilbene Acid by human liver microsomes and hepatocytes: involvement of cytochrome p450 reaction phenotyping, inhibition, and induction studies.
    Hua X; Peng X; Tan S; Li C; Wang W; Luo M; Fu Y; Zu Y; Smyth H
    J Agric Food Chem; 2014 Oct; 62(43):10604-14. PubMed ID: 25272989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The kinetics of aflatoxin B1 oxidation by human cDNA-expressed and human liver microsomal cytochromes P450 1A2 and 3A4.
    Gallagher EP; Kunze KL; Stapleton PL; Eaton DL
    Toxicol Appl Pharmacol; 1996 Dec; 141(2):595-606. PubMed ID: 8975785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of specifically active recombinant fused enzymes consisting of CYP3A4, NADPH-cytochrome P450 oxidoreductase, and cytochrome b5.
    Inui H; Maeda A; Ohkawa H
    Biochemistry; 2007 Sep; 46(35):10213-21. PubMed ID: 17691855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of CYP3A4 in human hepatic diltiazem N-demethylation: inhibition of CYP3A4 activity by oxidized diltiazem metabolites.
    Sutton D; Butler AM; Nadin L; Murray M
    J Pharmacol Exp Ther; 1997 Jul; 282(1):294-300. PubMed ID: 9223567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative studies of in vitro inhibition of cytochrome P450 3A4-dependent testosterone 6beta-hydroxylation by roxithromycin and its metabolites, troleandomycin, and erythromycin.
    Yamazaki H; Shimada T
    Drug Metab Dispos; 1998 Nov; 26(11):1053-7. PubMed ID: 9806945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coexpression of genetically engineered fused enzyme between yeast NADPH-P450 reductase and human cytochrome P450 3A4 and human cytochrome b5 in yeast.
    Hayashi K; Sakaki T; Kominami S; Inouye K; Yabusaki Y
    Arch Biochem Biophys; 2000 Sep; 381(1):164-70. PubMed ID: 11019832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The thermodynamic landscape of testosterone binding to cytochrome P450 3A4: ligand binding and spin state equilibria.
    Roberts AG; Campbell AP; Atkins WM
    Biochemistry; 2005 Feb; 44(4):1353-66. PubMed ID: 15667229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resveratrol is a selective human cytochrome P450 1A1 inhibitor.
    Chun YJ; Kim MY; Guengerich FP
    Biochem Biophys Res Commun; 1999 Aug; 262(1):20-4. PubMed ID: 10448061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzymatic characteristics of CYP3A5 and CYP3A4: a comparison of in vitro kinetic and drug-drug interaction patterns.
    Emoto C; Iwasaki K
    Xenobiotica; 2006; 36(2-3):219-33. PubMed ID: 16702113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism-based inactivation of cytochrome P-450-3A4 by mifepristone (RU486).
    He K; Woolf TF; Hollenberg PF
    J Pharmacol Exp Ther; 1999 Feb; 288(2):791-7. PubMed ID: 9918590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential oxidation of mifepristone by cytochromes P450 3A4 and 3A5: selective inactivation of P450 3A4.
    Khan KK; He YQ; Correia MA; Halpert JR
    Drug Metab Dispos; 2002 Sep; 30(9):985-90. PubMed ID: 12167563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.